Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Postgraduate Medicine
|
September 24, 2010
Does placebo response differ between objective and subjective measures in children with attention-deficit/hyperactivity disorder?
Calvin R Sumner, Virginia S Haynes, Martin H Teicher, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
March 26, 2009
Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the Integrated Data Exploratory Analysis (IDEA) study
Jeffrey H Newcorn, Virginia K Sutton, Margaret D Weiss, et al.
Journal of Child and Adolescent Psychopharmacology
|
January 5, 2007
Placebo-controlled study of the effects of atomoxetine on bladder control in children with nocturnal enuresis
Calvin R Sumner, Kory J Schuh, Virginia K Sutton, et al.
Journal of Clinical Psychopharmacology
|
July 21, 2006
Decreased use of clonidine following treatment with atomoxetine in children with ADHD
Joseph A Johnston, Wenyu Ye, David L Van Brunt, et al.
Child and Adolescent Psychiatry and Mental Health
|
December 17, 2009
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children with ADHD and dyslexia
Calvin R Sumner, Susan Gathercole, Michael Greenbaum, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP
|
August 17, 2004
Improvement in health-related quality of life in children with ADHD: an analysis of placebo controlled studies of atomoxetine
Amy R Perwien, Douglas E Faries, Christopher J Kratochvil, et al.
The Journal of Nervous and Mental Disease
|
January 3, 2020
Pharmacogenomic Testing in Psychiatry: Ready for Primetime?
Gopalkumar Rakesh, Calvin R Sumner, Jeanne Leventhal Alexander, et al.
The Lancet. Psychiatry
|
November 28, 2016
Neuropsychiatric aspects of concussion
Rajiv Radhakrishnan, Amir Garakani, Lawrence S Gross, et al.
Journal of Psychiatric Practice
|
September 16, 2021
Selective Serotonin Reuptake Inhibitors: How Long Is Long Enough?
Robyn P Thom, Jeanne L Alexander, David Baron, et al.
Current Medical Research and Opinion
|
January 9, 2008
Effects of atomoxetine on attention-deficit/hyperactivity disorder in clinical pediatric treatment settings: a naturalistic study
Rosalie J Bakken, Martin Paczkowski, Hal P Kramer, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Postgraduate Medicine
|
September 24, 2010
Does placebo response differ between objective and subjective measures in children with attention-deficit/hyperactivity disorder?
Calvin R Sumner, Virginia S Haynes, Martin H Teicher, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
March 26, 2009
Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the Integrated Data Exploratory Analysis (IDEA) study
Jeffrey H Newcorn, Virginia K Sutton, Margaret D Weiss, et al.
Journal of Child and Adolescent Psychopharmacology
|
January 5, 2007
Placebo-controlled study of the effects of atomoxetine on bladder control in children with nocturnal enuresis
Calvin R Sumner, Kory J Schuh, Virginia K Sutton, et al.
Journal of Clinical Psychopharmacology
|
July 21, 2006
Decreased use of clonidine following treatment with atomoxetine in children with ADHD
Joseph A Johnston, Wenyu Ye, David L Van Brunt, et al.
Child and Adolescent Psychiatry and Mental Health
|
December 17, 2009
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children with ADHD and dyslexia
Calvin R Sumner, Susan Gathercole, Michael Greenbaum, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP
|
August 17, 2004
Improvement in health-related quality of life in children with ADHD: an analysis of placebo controlled studies of atomoxetine
Amy R Perwien, Douglas E Faries, Christopher J Kratochvil, et al.
The Journal of Nervous and Mental Disease
|
January 3, 2020
Pharmacogenomic Testing in Psychiatry: Ready for Primetime?
Gopalkumar Rakesh, Calvin R Sumner, Jeanne Leventhal Alexander, et al.
The Lancet. Psychiatry
|
November 28, 2016
Neuropsychiatric aspects of concussion
Rajiv Radhakrishnan, Amir Garakani, Lawrence S Gross, et al.
Journal of Psychiatric Practice
|
September 16, 2021
Selective Serotonin Reuptake Inhibitors: How Long Is Long Enough?
Robyn P Thom, Jeanne L Alexander, David Baron, et al.
Current Medical Research and Opinion
|
January 9, 2008
Effects of atomoxetine on attention-deficit/hyperactivity disorder in clinical pediatric treatment settings: a naturalistic study
Rosalie J Bakken, Martin Paczkowski, Hal P Kramer, et al.
Page
of 2